Abstract:Introduction: Genistin, as a kind of natural isoflavone glycoside, has good biological activity, and its weak absorption makes it closely related to intestinal flora. However, the role of the intestinal flora is still unclear and whether the metabolites produced by the intestinal flora are absorbed systemically is also variable. Methods: Genistin was fermented for 24 h based on fecal bacteria fermentation technology. The components were qualitatively and quantitatively analyzed by HPLC and UHPLC-Q-Exactive Orbitrap Mass spectrometry. The composition of intestinal flora in fermentation samples from fecal bacteria was detected by 16S rRNA sequencing. Five representative probiotics were cultured in vitro and fermented with genistin to determine similarities and differences in genistin metabolites by different bacteria at different times. Finally, the absorption results of metabolites by fermentation were verified by a Caco-2 cell monolayer. Results: The HPLC results of fecal fermentation showed that genistein levels increased from 0.0139 ± 0.0057 mg/mL to 0.0426 ± 0.0251 mg/mL and two new metabolites were produced. A total of 46 metabolites following fecal fermentation were identified, resulting from various biotransformation reaction products, such as decarbonylation, hydroxylation, and methylation. Simultaneously, the 16S rRNA results showed that the intestinal flora changed significantly before and after fermentation and that the intestinal microorganisms in the control (Con) group and the fermentation (Fer) group showed a significant separation trend. Five genera, Lactobacillus , Bifidobacterium , Parabacteroides , Sutterella , and Dorea , were considered the dominant flora for genistin fermentation. The qualitative results of fermentation of genistin by five probiotics at different times showed that there were significant differences in small molecule metabolites by fermentation of different bacteria. Meanwhile, most metabolites could be identified following fecal bacteria fermentation, which verified the importance of the dominant bacteria in the feces for the biotransformation of components. Finally, the absorption results of the metabolites based on the Caco-2 cell monolayer showed that 14 metabolites could be absorbed into the circulation in vivo through the mesentery. Discussion: The small molecule metabolites of genistin by fermentation of fecal bacteria can be well absorbed systemically by the body. These studies provide a reference value for explaining the transformation and absorption of flavonoid glycosides in the intestine.

Biotransformation of Liquiritigenin into Characteristic Metabolites by the Gut Microbiota

Characterization of the global metabolic profile of liquiritin in rat plasma, urine, bile and feces based on UHPLC-FT-ICR MS

C5-hydroxylation of liquiritigenin is catalyzed selectively by CYP1A2.

Pharmacological activities and pharmacokinetics of liquiritin: A review

The changes of intestinal microbiota and metabolomics during the inhibition of bladder cancer by liquiritigenin

Metabolic Transformation of Gentiopicrin, a Liver Protective Active Ingredient, Based on Intestinal Bacteria

Mixed micelles for enhanced oral bioavailability and hypolipidemic effect of liquiritin: preparation, in vitro and in vivo evaluation

Identification of metabolites of FR429, a potential antitumor ellagitannin, transformed by rat intestinal bacteria in vitro, based on liquid chromatography-ion trap-time of flight mass spectrometry analysis.

Characterization of metabolites of liquirtigenin in rats by UPLC-Q-TOF/MS

Study on biotransformation and absorption of genistin based on fecal microbiota and Caco-2 cell

Identification of the Metabolites of Myricitrin Produced by Human Intestinal Bacteria in Vitro Using Ultra-Performance Liquid Chromatography/quadrupole Time-of-flight Mass Spectrometry.

Effects of Oral Liquiritigenin Inoculation on Gut Microbiota and Gene Expression in Intestinal and Extraintestinal Tissues of Mice

Comprehensive Characterization of the in Vitro and in Vivo Metabolites of Ziyuglycoside I in Rat Microsome, Intestinal Flora, Excretion Specimen and Fresh Tissues Based on LC-Q-TOF/MS.

An Integrated Approach to Characterize Intestinal Metabolites of Four Phenylethanoid Glycosides and Intestinal Microbe-Mediated Antioxidant Activity Evaluation in Vitro Using UHPLC-Q-Exactive High-Resolution Mass Spectrometry and a 1,1-Diphenyl-2-picrylhydrazyl-based Assay.

De novo biosynthesis of liquiritin in Saccharomyces cerevisiae

Biotransformation of Total Saponins in Siraitia Fructus by Human Intestinal Microbiota of Normal and Type 2 Diabetic Patients: Comprehensive Metabolite Identification and Metabolic Profile Elucidation Using LC-Q-TOF/MS.

Metabolism of flavonoids in human: a comprehensive review.

Divergent metabolism of two lychee (Litchi chinensis Sonn.) pulp flavonols and their modulatory effects on gut microbiota: Discovery of hydroxyethylation in vitro colonic fermentation

Study on Biotransformation by Intestinal Bacteria to Chinese Herbal Medicines

Absorption and biotransformation of four compounds in the Guizhi decoction in the gastrointestinal tracts of rats

Biotransformation of Flavonoids Improves Antimicrobial and Anti-Breast Cancer Activities in Vitro